Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '584 Appeal

IMO TPL is very much in control of this company and the SP will rise when it's to their advantage for it to rise.

TPL controls the communications to the shareholder (in fact all communication), controls the licensing, and now it seems even the distribution of revenue as evidenced by the February licenses and possibly the J3 settlement.

.

Wonder what Leckrone's 'fiduciary responsibility' is??

Share
New Message
Please login to post a reply